Jonathan Alexander Terrett
64Patents
10h-index
62Co-inventors
81Inventor score
Filing activity: Nov 25, 1997 → Feb 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7261892B2 | Methods for diagnosis and treatment of epithelial-derived cancers | Physics | 35 | Expired |
| US8268970B2 | Human antibodies that bind mesothelin, and uses thereof | Chemistry; Metallurgy | 32 | Active |
| US9228023B2 | Anti-ROR1 antibodies and methods of use for treatment of cancer | Chemistry; Metallurgy | 31 | Active |
| US10179817B2 | Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof | Chemistry; Metallurgy | 25 | Active |
| US10233244B2 | Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof | Chemistry; Metallurgy | 17 | Active |
| US10336824B2 | Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof | Chemistry; Metallurgy | 12 | Active |
| US9102738B2 | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) | Chemistry; Metallurgy | 12 | Active |
| US8399623B2 | Human antibodies that bind mesothelin, and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US7745156B2 | Methods for diagnosis and treatment of epithelial-derived cancers | Physics | 11 | Active |
| US10736919B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 10 | Active |
| US8383779B2 | Human antibodies that bind mesothelin, and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US8680247B2 | Monoclonal antibodies against glypican-3 | Chemistry; Metallurgy | 9 | Active |
| US10857184B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 8 | Active |
| US10669339B2 | Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof | Chemistry; Metallurgy | 8 | Active |
| US8425904B2 | Human antibodies that bind mesothelin, and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US10745481B2 | Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof | Chemistry; Metallurgy | 8 | Active |
| US11166985B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 7 | Active |
| US9732160B2 | Methods of treating acute myeloid leukemia with antibodies to bone marrow stromal antigen 1 | Chemistry; Metallurgy | 7 | Active |
| US10881689B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 6 | Active |
| US10729725B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 6 | Active |
| US8222375B2 | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | Chemistry; Metallurgy | 6 | Active |
| US11071755B1 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 6 | Active |
| US9932411B2 | Antibodies | Chemistry; Metallurgy | 5 | Active |
| US7220557B2 | METH1 polynucleotides | Chemistry; Metallurgy | 5 | Expired |
| US11135247B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.